About Uniprogen Biotech Private Limited
Data last updated:
Uniprogen Biotech Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2010PTC198320. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.05 Cr and a paid-up capital of ₹1.01 Cr. It is led by directors including Santanu Nayak and Anandkumar Bhanupratap Singh.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Shop No 16 Ashapura Chs Plot No 51 Sec 19 Airoli, Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.87 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹7.86 Lakh (net margin -4.2%) and EBITDA of ₹38,869 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uni-progen-biotech-private-limited.business.site.
Company details
Contact details
Uniprogen Biotech Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is uni-progen-biotech-private-limited.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 16 Ashapura Chs Plot No 51 Sec 19 Airoli, Navi Mumbai, Maharashtra, India – 400708
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Uniprogen Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uniprogen Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Uniprogen Biotech Private Limited, buy the company report.
Financials of Uniprogen Biotech Private Limited
FY 2021 filings availableUniprogen Biotech Private Limited reported revenue of ₹1.87 Cr (down 30% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 30% fall in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.87 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38,869 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | -4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uniprogen Biotech Private Limited, buy the company report.
Board of directors of Uniprogen Biotech Private Limited
Uniprogen Biotech has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santanu Nayak | Director | 15 Jan 2010 | 16 Years 9 Months | Current |
| Anandkumar Bhanupratap Singh | Director | 15 Jan 2010 | 16 Years 9 Months | Current |
| Priyajit Chakraborty | Additional Director | 19 Mar 2020 | 6 Years 7 Months | Current |
| Boomi Nathan Shankar | Director | 02 Jan 2010 | 16 Years 9 Months | Current |
| Madhu Mehta | Director | 01 Apr 2013 | 13 Years 7 Months | Current |
| Nilesh Rampratap Chaubey | Director | 03 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
Uniprogen Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iuvenis Healthcare Private Limited | ₹1.88 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Castor and Fischer Pharma Private Limited | ₹1.87 Cr (FY 2025) | 25.0% | Chalakudy, Kerala, India | |||
| Pashupati Chemicals & Pharmaceuticals Limited | ₹1.87 Cr (FY 2024) | -23.0% | Kolkata, West Bengal, India | |||
| Uniprogen Biotech Private Limitedthis company | ₹1.87 Cr (FY 2020) | -₹7.86 Lakh | -4.2% | -30.0% | 3 | Navi Mumbai, Maharashtra, India |
| Mo Medicine (OPC) Private Limited | ₹1.87 Cr (FY 2025) | 80.0% | Bhubaneswar, Odisha, India | |||
| Astorion Pharmaceuticals Private Limited | ₹1.87 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Rose Pharmaco Pvt Ltd | ₹1.86 Cr (FY 2024) | 20.0% | Guwahati, Assam, India |
To see the full peer comparison of Uniprogen Biotech Private Limited, buy the company report.
Auditor
Uniprogen Biotech Private Limited is audited by P M DALVI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P M DALVI & CO | FY 2020 | 102065W |
Shareholding
The shareholding of Uniprogen Biotech Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Uniprogen Biotech Private Limited, buy the company report.
Legal cases
Uniprogen Biotech Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln.-PGA) | Filed against the company by an individual | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln-IDA) | Filed against the company by an individual | Disposed |
To see the full case history of Uniprogen Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uniprogen Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Uniprogen Biotech Private Limited has a workforce of 3 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Uniprogen Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Uniprogen Biotech Private Limited, buy the company report.
Recent activity
Uniprogen Biotech Private Limited has 11 board changes on record since 2010: 6 appointments and 5 cessations. The latest: Priyajit Chakraborty was appointed as Additional Director on 19 Mar 2020.
2 earlier events are in the company report.
Frequently asked questions
Uniprogen Biotech is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 January 2010 (16+ years old) and is registered under CIN U51909MH2010PTC198320.
Uniprogen Biotech has 6 current directors:
- Santanu Nayak - Director
- Anandkumar Bhanupratap Singh - Director
- Priyajit Chakraborty - Additional Director
- Boomi Nathan Shankar - Director
- Madhu Mehta - Director
- Nilesh Rampratap Chaubey - Director
The latest financial statements of Uniprogen Biotech on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
No. Uniprogen Biotech has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Uniprogen Biotech is U51909MH2010PTC198320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uniprogen Biotech has 2 court cases on record: 2 filed against it.
Uniprogen Biotech was incorporated on 02 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Uniprogen Biotech by revenue are Iuvenis Healthcare Private Limited, Castor and Fischer Pharma Private Limited, Pashupati Chemicals & Pharmaceuticals Limited, Mo Medicine (OPC) Private Limited, Astorion Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Priyajit Chakraborty was appointed as Additional Director on 19 Mar 2020. Bablu Ramchandra Gupta ceased to be Director on 25 Apr 2019. Soundarrajan Santhanaraman ceased to be Director on 25 Apr 2019. Uniprogen Biotech has 11 board changes on record in total.
Uniprogen Biotech can be reached through the website uni-progen-biotech-private-limited.business.site. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Uniprogen Biotech is at Shop No 16 Ashapura Chs Plot No 51 Sec 19 Airoli, Navi Mumbai, Maharashtra, India – 400708.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
